Primary Prevention with Aspirin Reduces Mortality in Type 2 Diabetes and Heart Failure: Results from the THIN Primary Care Database

Mar-18

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Dr Charbel Abi Khalil, Weill Cornell Medicine – Qatar, Qatar Foundation, Education City, P.O. Box 24144, Doha, Qatar – Email: cha2022@med.cornell.edu – Profile: https://vivo.weill.cornell.edu/display/cwid-cha2022

JOURNAL : Journal of the American College of Cardiology

REFERENCE: 71(11):A1851

DOI : 10.1016/S0735-1097(18)32392-1

Primary Prevention with Aspirin Reduces Mortality in Type 2 Diabetes and Heart Failure: Results from the THIN Primary Care Database

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study